PNC Financial Services Group’s NovaBridge Biosciences American Depositary Shares NBP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$3.9K Hold
2,000
– – ﹤0.01% 4474
2026
Q1
$4.92K Buy
2,000
+1,000
+100% +$3.35K ﹤0.01% 4277
2025
Q4
$3.98K Hold
1,000
– – ﹤0.01% 4321
2025
Q3
$3.78K Buy
+1,000
New +$3.39K ﹤0.01% 4310
2022
Q3
– Sell
-114
Closed -$1K – 4526
2022
Q2
$1K Sell
114
-732
-87% -$8.78K ﹤0.01% 4344
2022
Q1
$14K Buy
846
+424
+100% +$10.9K ﹤0.01% 3728
2021
Q4
$21K Sell
422
-235
-36% -$14.1K ﹤0.01% 3527
2021
Q3
$48K Buy
657
+494
+303% +$35.7K ﹤0.01% 3096
2021
Q2
$13K Buy
+163
New +$10.8K ﹤0.01% 3624

Other funds holding NBP

PNC Financial Services Group's NBP Position: Q2 2026 in Review

PNC Financial Services Group held its NovaBridge Biosciences American Depositary Shares (NBP) position steady in Q2 2026 at 2,000 shares worth $3.9K. The position accounts for ﹤0.01% of the portfolio, ranked #4474.

PNC Financial Services Group first reported a position in NBP in Q2 2021 and has held it in 9 quarters since. The position peaked at $48K in Q3 2021. 49 funds tracked by Wall St. Rank hold NBP as of Q2 2026.

  • PNC Financial Services Group held 2,000 shares of NovaBridge Biosciences American Depositary Shares worth $3.9K as of Q2 2026.
  • PNC Financial Services Group left its NovaBridge Biosciences American Depositary Shares share count unchanged in Q2 2026.
  • NovaBridge Biosciences American Depositary Shares made up ﹤0.01% of PNC Financial Services Group's portfolio in Q2 2026, its #4474 holding.
  • PNC Financial Services Group first reported a position in NovaBridge Biosciences American Depositary Shares in Q2 2021 and has held it in 9 quarters since.
  • PNC Financial Services Group's NovaBridge Biosciences American Depositary Shares position peaked at $48K in Q3 2021.
  • 49 funds tracked by Wall St. Rank held NovaBridge Biosciences American Depositary Shares as of Q2 2026.

Based on PNC Financial Services Group's 13F filing for Q2 2026, filed 7 Aug 2026.